WHO ICTRP trial
A study of oliceridine ED50 and ED95 required for bronchoscopy response under…
ChiCTR2400086635 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400086635 |
|---|---|
| Public title | A study of oliceridine ED50 and ED95 required for bronchoscopy response under sedation with ciprofol |
| Scientific title | A study of oliceridine ED50 and ED95 required for bronchoscopy response under sedation with ciprofol |
| Primary sponsor | The First Affiliated Hospital of Guangxi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Anesthesia |
| Interventions | Male group:Oliceridine;Female group:Oliceridine |
| Registration date | Jul 8, 2024 |
| Target size | Male group:20;Female group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: